| Pharmaceutical active ingredients: |
| Daunorubicin Hydrochloride |
| Available forms, composition and doses of Daunorubicin: |
| Injectable; Injection; Daunorubicin Hydrochloride 20 mg |
| Daunorubicin medical category: |
| Human:Antineoplastic agentsCytotoxic chemotherapy |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| L01DB02 - Daunorubicin |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| Sanofi-Aventis |
| Trade name |
Active ingredients |
Pharmaceutical company |
|
Daunorubicin | Daunorubicin Hydrochloride | Bigmar Bioren Pharmaceuticals |
| Daunorubicin | Daunorubicin Hydrochloride | Lans-Pharm |
| Daunorubicin | Daunorubicin Hydrochloride | Mayne Pharma |
| Daunorubicin | Daunorubicin Hydrochloride | Novopharm |
| Daunorubicin | Daunorubicin Hydrochloride | Pfizer |
| Daunorubicin | Daunorubicin Hydrochloride | Sicor Pharmaceuticals |
| Daunorubicin | Daunorubicin Hydrochloride | SuperGen |
| Daunorubitec | Daunorubicin Hydrochloride | United Biotech |
| Daunotec | Daunorubicin Hydrochloride | Cipla; OncoCare Cancer Centre |
| Rubilem | Daunorubicin Hydrochloride | Teva; Lemery |